Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapeutics crawled date : 2022 - 01 - 06 save search
Iovance Biotherapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022
Published: 2022-01-06 (Crawled : 23:00) - globenewswire.com
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: 1.56%
H: 4.66%
C: -0.12%
health thc conference therapeutics j.p. morgan healthcare conference iot
TransCode Therapeutics To Participate at H.C. Wainwright BioConnect Conference
Published: 2022-01-06 (Crawled : 21:00) - globenewswire.com
RNAZ | $0.5195 3.59% 3.46% 270K
|
Professional, Scientific, and T...
|
| O: 2.75%
H: 0.0%
C: -7.25%
conference therapeutics
Finch Therapeutics Further Strengthens Patent Portfolio with Two New U.S. Patents Granted for FIN-211, an Investigational Microbiome Therapeutic in Development for Autism Spectrum Disorder
Published: 2022-01-06 (Crawled : 20:00) - biospace.com/
FNCH | $2.4 -4.76% -5.0% 26K
|
Professional, Scientific, and T...
|
| O: 0.64%
H: 3.48%
C: -2.53%
fin-211 order patent granted therapeutics ism
Better Therapeutics Highlights Recent Progress and Updates Outlook Through Q1 2022
Published: 2022-01-06 (Crawled : 19:00) - biospace.com/
BTTX | $0.009 -65.02% 180K
|
|
| O: -2.66%
H: 8.0%
C: 5.47%
therapeutics
Exelixis and Iconic Therapeutics Amend Option and License Agreement for XB002, an Antibody-Drug Conjugate Targeting Tissue Factor
Published: 2022-01-06 (Crawled : 15:00) - biospace.com/
ZYME | $8.68 -1.92% -1.96% 730K
|
Health Technology
|
| O: 1.85%
H: 0.0%
C: -8.52%
EXEL | $22.47 -1.75% -1.78% 2.6M
|
Health Technology
|
| O: 0.5%
H: 1.27%
C: 0.94%
xb002 drug license therapeutics antibody
Aprea Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference on Thursday, January 13, 2022
Published: 2022-01-06 (Crawled : 14:30) - biospace.com/
APRE | $5.73 -1.29% 870
|
Health Technology
|
| O: -0.28%
H: 4.09%
C: -3.89%
health thc conference therapeutics j.p. morgan healthcare conference
Bolt Biotherapeutics Doses First Patient with BDC-1001 in Combination with OPDIVO® (nivolumab) in Ongoing Phase 1/2 Clinical Trial for the Treatment of HER2-Expressing Solid Tumors
Published: 2022-01-06 (Crawled : 14:30) - biospace.com/
BOLT | $1.15 3.6% 3.48% 89K
|
|
| O: -4.05%
H: 2.98%
C: -7.2%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: -1.17%
H: 0.11%
C: -0.39%
bdc-1001 opdivo treatment solid tumors ongoing trial therapeutics 100 phase 1 iot her2- her2 nivolumab
i2O Therapeutics Announces Research Collaboration and Option Agreement with Janssen to Investigate the Oral Delivery of Macromolecules
Published: 2022-01-06 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -1.75%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
ces research liver therapeutics collaboration
Sarepta Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
Published: 2022-01-06 (Crawled : 14:00) - biospace.com/
SRPT | $116.59 -1.1% -1.12% 500K
|
Health Technology
|
| O: 0.23%
H: 4.5%
C: 3.11%
health thc conference therapeutics j.p. morgan healthcare conference
Intellia Therapeutics Highlights Strategic Priorities and Anticipated Development Milestones for 2022
Published: 2022-01-06 (Crawled : 14:00) - biospace.com/
REGN | $893.66 -0.84% -0.84% 450K
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
NTLA | $21.3 -0.93% -0.94% 1.1M
|
Health Technology
|
| O: -0.35%
H: 3.81%
C: 1.53%
therapeutics intel milestone
Clinical Evaluation Finds Arch Therapeutics’ AC5® Advanced Wound System Effective in Healing Complex Chronic Wounds
Published: 2022-01-06 (Crawled : 14:00) - biospace.com/
ARTH | $1.16 -17.78% 1.9K
|
Manufacturing
|
| O: 0.0%
H: 0.92%
C: 0.92%
ac5 system therapeutics
Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors
Published: 2022-01-06 (Crawled : 14:00) - biospace.com/
XLO | $1.23 0.0% 150K
|
Professional, Scientific, and T...
|
| O: 0.33%
H: 5.33%
C: -4.47%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -2.58%
H: 1.2%
C: 0.05%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
LEGN | $47.16 -3.42% -3.54% 820K
|
Health Technology
|
| O: -7.55%
H: 3.65%
C: 3.07%
GILD | News | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: -0.96%
H: 0.58%
C: -0.12%
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
|
| O: -0.56%
H: 2.27%
C: -4.25%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.64%
H: 0.67%
C: 0.01%
AKRO | $20.535 -4.93% -5.19% 760K
|
Health Technology
|
| O: -0.35%
H: 4.23%
C: 3.03%
therapeutics
Melinta Therapeutics President and CEO Christine Ann Miller Elected to Board of Directors of Iveric Bio
Published: 2022-01-06 (Crawled : 14:00) - biospace.com/
ISEE | $39.95 0.38% 0.38% 0
|
Health Technology
|
| O: 0.21%
H: 1.74%
C: -2.09%
ceo therapeutics
Alterity Therapeutics Granted New US Patent for Compounds for Neurodegenerative Diseases Including Parkinson's and Alzheimer's
Published: 2022-01-06 (Crawled : 13:30) - biospace.com/
ATHE | $2.15 6.97% 6.51% 27K
|
Health Technology
|
| O: 26.61%
H: 17.14%
C: 5.71%
alzheimer parkinson patent granted therapeutics disease neurodegenerative alzheimer’s grant alzheimer's
Alterity Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
Published: 2022-01-04 (Crawled : 13:27) - alteritytherapeutics.com
ATHE | $2.15 6.97% 6.51% 27K
|
Health Technology
|
| O: 1.65%
H: 5.5%
C: 1.97%
conference therapeutics
Alterity Therapeutics Granted New US Patent for Compounds for Neurodegenerative Diseases Including Parkinson’s and Alzheimer’s
Published: 2022-01-05 (Crawled : 13:27) - alteritytherapeutics.com
ATHE | $2.15 6.97% 6.51% 27K
|
Health Technology
|
| O: 26.61%
H: 17.14%
C: 5.71%
alzheimer parkinson patent granted therapeutics disease neurodegenerative alzheimer’s grant alzheimer's
Sensei Biotherapeutics Announces Executive Promotions
Published: 2022-01-06 (Crawled : 13:00) - investors.senseibio.com
SNSE | $0.98 -2.0% -2.04% 32K
|
|
| O: 0.53%
H: 0.18%
C: -1.6%
ces therapeutics iot
Adagio Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
Published: 2022-01-06 (Crawled : 12:00) - globenewswire.com
ADGI | $4.83 -1.45%
|
|
| O: -3.69%
H: 1.98%
C: -2.24%
health thc conference therapeutics j.p. morgan healthcare conference
Alterity Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
Published: 2022-01-05 (Crawled : 10:00) - biospace.com/
ATHE | $2.15 6.97% 6.51% 27K
|
Health Technology
|
| O: 1.65%
H: 5.5%
C: 1.97%
conference therapeutics
Werewolf Therapeutics to Present at the H.C. Wainwright Bioconnect Conference
Published: 2022-01-05 (Crawled : 10:00) - biospace.com/
HOWL | $5.87 0.51% 0.51% 120K
|
Professional, Scientific, and T...
|
| O: -0.75%
H: 2.1%
C: -0.59%
conference therapeutics
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.